AU2001290311A1 - Thienopyrimidine compounds and their salts and process for preparation of both - Google Patents

Thienopyrimidine compounds and their salts and process for preparation of both

Info

Publication number
AU2001290311A1
AU2001290311A1 AU2001290311A AU9031101A AU2001290311A1 AU 2001290311 A1 AU2001290311 A1 AU 2001290311A1 AU 2001290311 A AU2001290311 A AU 2001290311A AU 9031101 A AU9031101 A AU 9031101A AU 2001290311 A1 AU2001290311 A1 AU 2001290311A1
Authority
AU
Australia
Prior art keywords
salts
preparation
thienopyrimidine compounds
thienopyrimidine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290311A
Inventor
Kimiko Ichikawa
Seiichi Ikeyama
Mitsumasa Takada
Nobuhiro Umeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Soda Co Ltd
Original Assignee
Nippon Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co Ltd filed Critical Nippon Soda Co Ltd
Publication of AU2001290311A1 publication Critical patent/AU2001290311A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2001290311A 2000-09-29 2001-09-28 Thienopyrimidine compounds and their salts and process for preparation of both Abandoned AU2001290311A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-299872 2000-09-29
JP2000299872 2000-09-29
PCT/JP2001/008530 WO2002026745A1 (en) 2000-09-29 2001-09-28 Thienopyrimidine compounds and their salts and process for preparation of both

Publications (1)

Publication Number Publication Date
AU2001290311A1 true AU2001290311A1 (en) 2002-04-08

Family

ID=18781622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290311A Abandoned AU2001290311A1 (en) 2000-09-29 2001-09-28 Thienopyrimidine compounds and their salts and process for preparation of both

Country Status (7)

Country Link
EP (1) EP1329454A1 (en)
JP (1) JPWO2002026745A1 (en)
KR (1) KR20030034232A (en)
CN (1) CN1458933A (en)
AU (1) AU2001290311A1 (en)
CA (1) CA2423981A1 (en)
WO (1) WO2002026745A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217956B1 (en) 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. NEW DERIVATIVES OF 4-AMINOTIENE (2,3-D) PIRIMIDIN-6-CARBONITRILE.
TW200621257A (en) * 2004-10-20 2006-07-01 Astellas Pharma Inc Pyrimidine derivative fused with nonaromatic ring
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
KR101288144B1 (en) * 2005-06-14 2013-07-18 아스카 세이야쿠 가부시키가이샤 Thienopyrimidine derivative
KR101507182B1 (en) * 2006-12-07 2015-03-30 제넨테크, 인크. Phosphoinositide 3-kinase inhibitor compounds and methods of use
US20100093714A1 (en) * 2008-10-13 2010-04-15 Devraj Chakravarty AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
SI2540728T1 (en) 2010-02-17 2019-06-28 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN104053661B (en) 2011-11-23 2018-06-19 癌症研究技术有限公司 The thienopyrimidines inhibitor of atypical protein kinase C
KR20140110066A (en) * 2012-01-10 2014-09-16 에프. 호프만-라 로슈 아게 Thienopyrimidine compounds
CN103664991B (en) * 2012-09-19 2016-12-28 中国科学院福建物质结构研究所 Thiophene [2,3 d] pyrimidine derivatives, Its Preparation Method And Use
CA2905751A1 (en) 2013-03-13 2014-10-09 Forma Therapeutics, Inc. Novel compounds and compositions for inhibition of fasn
SG11201804901WA (en) 2015-12-22 2018-07-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
EA201992780A1 (en) 2017-06-21 2020-06-02 ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR TREATMENT OF CANCER, INFLAMMATORY DISEASES, RAS OPATIAS AND FIBROUS DISEASE
WO2019023651A2 (en) * 2017-07-28 2019-01-31 Massachusetts Institute Of Technology Small molecule modulators of the androgen receptor
TWI767148B (en) 2018-10-10 2022-06-11 美商弗瑪治療公司 Inhibiting fatty acid synthase (fasn)
EP3873214A4 (en) 2018-10-29 2022-07-13 Forma Therapeutics, Inc. Solid forms of (4-(2-fluoro-4-(1-methyl-1 h-benzo[d]imidazol-5-yl)benzoyl) piperazin-1-yl)(1-hydroxycyclopropyl)methanone
US20230148450A9 (en) * 2019-03-01 2023-05-11 Revolution Medicines, Inc. Bicyclic heteroaryl compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19632423A1 (en) * 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidines
DE19644228A1 (en) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19752952A1 (en) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidines

Also Published As

Publication number Publication date
CA2423981A1 (en) 2003-03-28
EP1329454A1 (en) 2003-07-23
CN1458933A (en) 2003-11-26
JPWO2002026745A1 (en) 2004-02-05
WO2002026745A1 (en) 2002-04-04
KR20030034232A (en) 2003-05-01

Similar Documents

Publication Publication Date Title
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001290311A1 (en) Thienopyrimidine compounds and their salts and process for preparation of both
HRP20040350A2 (en) NOVEL ?-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR US COMPOUNDS
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
AU2557500A (en) Methods of making compounds
AU2002241793A1 (en) Process for the preparation of organoclays
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2002238421A1 (en) Process for the preparation of phenethylamine derivatives
AU2001288092A1 (en) Method of crystallization
AU2001262226A1 (en) Process for the preparation of sterically hindered aryloxyamines
HK1054926A1 (en) Process for the preparation of pyrazolopyrimidinones
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
AU2001284469A1 (en) Methods for crystallization of hydroxycarboxylic acids
AU2002222687A1 (en) Process for preparation of polyhydric alcohols
AU2002213477A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
AU2001248766A1 (en) Process for preparation of sulfonamide derivatives and crystals thereof
AU2001220267A1 (en) Novel 1beta-methylcarbapenem derivatives and process of preparation thereof
AU2001273189A1 (en) Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid
AU2001260607A1 (en) Nitrile compounds and process for their preparation
AU2001274541A1 (en) Process for the preparation of cephem compounds
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU5534299A (en) Process for preparation of 2-aminothiazolecarboxamide derivatives
AU2002211034A1 (en) Aziridinylquinolinedione derivatives and process for their preparation
AU2001237790A1 (en) Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid
AU2001286268A1 (en) Method of forming complex